Day One Biopharmaceuticals is a startup based in All, 2 tracked investors.
Day One Biopharmaceuticals is a startup based in All. Brouky records 2 investors associated with the company.
Day One Biopharmaceuticals focuses on developing new medicines for children with pediatric low-grade glioma (pLGG) and provides resources to help families navigate diagnosis and treatment. The team includes experts in pediatric oncology, nursing, and drug development and aims to accelerate therapies for kids with pLGG.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.